Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Preclinical and clinical safety data includes [5] : No evidence of mutagenic activity, chromosomal aberrations, or micronucleus formation in genotoxicity studies 6-month chronic oral administration studies in rats showed no toxicological concerns 9-month studies in cynomolgus monkeys revealed general safety Six human clinical trials spanning 0.25 mg to 30 mg doses for up to 6 months No serious adverse events or withdrawals related to AOD9604 intake No anti-AOD9604 antibodies detected, indicating low immunogenic potential No changes in vital signs, physical examinations, electrocardiograms, or safety-related laboratory parameters Research Applications A Quick Review AOD9604 is a peptide compound that has shown potential in research related to lipid metabolism, energy balance, and tissue regeneration
The common peptide mistakes guide covers this and other errors that undermine research outcomes
The soreness correlates with injection technique: reviews mentioning "slow injection over 30 seconds" report 28% less soreness than those describing "quick push" technique (pattern analysis from 340 reviews specifying technique)
This single event is set to open the floodgates, making life-changing treatments affordable for millions of people
Oxidative Medicine and Cellular Longevity, 2012, 324832
Product Overview 5-Amino-1MQ (5-amino-1-methylquinolinium) is a selective, membrane-permeable small molecule inhibitor of nicotinamide N-methyltransferase (NNMT)
